Literature DB >> 26216637

Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

Xiaofei Yu1, Chunqing Guo1, Paul B Fisher1, John R Subjeck2, Xiang-Yang Wang3.   

Abstract

Scavenger receptors constitute a large family of evolutionally conserved protein molecules that are structurally and functionally diverse. Although scavenger receptors were originally identified based on their capacity to scavenge modified lipoproteins, these molecules have been shown to recognize and bind to a broad spectrum of ligands, including modified and unmodified host-derived molecules or microbial components. As a major subset of innate pattern recognition receptors, scavenger receptors are mainly expressed on myeloid cells and function in a wide range of biological processes, such as endocytosis, adhesion, lipid transport, antigen presentation, and pathogen clearance. In addition to playing a crucial role in maintenance of host homeostasis, scavenger receptors have been implicated in the pathogenesis of a number of diseases, e.g., atherosclerosis, neurodegeneration, or metabolic disorders. Emerging evidence has begun to reveal these receptor molecules as important regulators of tumor behavior and host immune responses to cancer. This review summarizes our current understanding on the newly identified, distinct functions of scavenger receptors in cancer biology and immunology. The potential of scavenger receptors as diagnostic biomarkers and novel targets for therapeutic interventions to treat malignancies is also highlighted.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer immunotherapy; Dendritic cells; Scavenger receptor; Tumor immunity; Tumor-associated macrophage

Mesh:

Substances:

Year:  2015        PMID: 26216637      PMCID: PMC4631385          DOI: 10.1016/bs.acr.2015.04.004

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  328 in total

Review 1.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

2.  LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells.

Authors:  Stefania Parlato; Giulia Romagnoli; Francesca Spadaro; Irene Canini; Paolo Sirabella; Paola Borghi; Carlo Ramoni; Ilaria Filesi; Silvia Biocca; Lucia Gabriele; Filippo Belardelli
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

3.  Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.

Authors:  Gaetano Zizzo; Brendan A Hilliard; Marc Monestier; Philip L Cohen
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

4.  17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers.

Authors:  G A Graf; K L Roswell; E J Smart
Journal:  J Lipid Res       Date:  2001-09       Impact factor: 5.922

5.  Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport.

Authors:  Yumiko Nakagawa-Toyama; Ken-ichi Hirano; Ken-ichi Tsujii; Makoto Nishida; Jun-ichiro Miyagawa; Naohiko Sakai; Shizuya Yamashita
Journal:  Atherosclerosis       Date:  2005-06-20       Impact factor: 5.162

6.  Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.

Authors:  Ying Chao; Milan Makale; Priya Prakash Karmali; Yuriy Sharikov; Igor Tsigelny; Sergei Merkulov; Santosh Kesari; Wolf Wrasidlo; Erkki Ruoslahti; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2012-04-26       Impact factor: 4.774

7.  Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells.

Authors:  Brent Berwin; Justin P Hart; Stuart Rice; Cecilia Gass; Salvatore V Pizzo; Steven R Post; Christopher V Nicchitta
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

8.  Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

Authors:  Jian Huang; Da-Li Zheng; Feng-Song Qin; Na Cheng; Hui Chen; Bing-Bing Wan; Yu-Ping Wang; Hua-Sheng Xiao; Ze-Guang Han
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy.

Authors:  Jae-Yoon Shin; Yoosoo Yang; Paul Heo; Ji-Chun Lee; Byoungjae Kong; Jae Youl Cho; Keejung Yoon; Cheol-Su Shin; Jin-Ho Seo; Sung-Gun Kim; Dae-Hyuk Kweon
Journal:  Int J Nanomedicine       Date:  2012-06-06
View more
  32 in total

Review 1.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Authors:  Chayanon Ngambenjawong; Heather H Gustafson; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

2.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

Review 3.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

Review 4.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

5.  PepFect14 Signaling and Transfection.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2022

6.  The scavenger receptor SCARA1 (CD204) recognizes dead cells through spectrin.

Authors:  Chen Cheng; Zhenzheng Hu; Longxing Cao; Chao Peng; Yongning He
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

Review 7.  Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

8.  PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.

Authors:  Allison M Martin; W Robert Bell; Ming Yuan; Lauren Harris; Bradley Poore; Antje Arnold; Elizabeth L Engle; Laura Asnaghi; Michael Lim; Eric H Raabe; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2020-01-01       Impact factor: 3.148

Review 9.  Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk.

Authors:  Gaigai Li; Prativa Sherchan; Zhouping Tang; Jiping Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 10.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.